Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Times Interest Earned (2017 - 2025)

Organogenesis Holdings has reported Times Interest Earned over the past 9 years, most recently at -$268.17 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$268.17 for Q4 2025, down 60.08% from a year ago — trailing twelve months through Dec 2025 was -$19.59 (down 2258.0% YoY), and the annual figure for FY2025 was -$19.59, down 2258.0%.
  • Times Interest Earned for Q4 2025 was -$268.17 at Organogenesis Holdings, down from -$49.94 in the prior quarter.
  • Over the last five years, Times Interest Earned for ORGO hit a ceiling of $27.83 in Q1 2025 and a floor of -$290.6 in Q4 2022.
  • Median Times Interest Earned over the past 5 years was $4.11 (2021), compared with a mean of -$32.61.
  • Biggest five-year swings in Times Interest Earned: surged 1354.62% in 2021 and later tumbled 6527.06% in 2024.
  • Organogenesis Holdings' Times Interest Earned stood at $23.15 in 2021, then plummeted by 1355.03% to -$290.6 in 2022, then soared by 99.13% to -$2.53 in 2023, then tumbled by 6527.06% to -$167.52 in 2024, then tumbled by 60.08% to -$268.17 in 2025.
  • The last three reported values for Times Interest Earned were -$268.17 (Q4 2025), -$49.94 (Q3 2025), and $18.8 (Q2 2025) per Business Quant data.